Previous 10 | Next 10 |
New York, New York--(Newsfile Corp. - September 11, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS). If you invested in Evolus stock or options and would like to d...
Are These The Best Health care Stocks To Trade Before September 2020? The pandemic has put health care stocks under the spotlight. As many biotechnology and pharmaceutical companies jump in to find the vaccines and treatments for COVID-19 , many investors are looking for top health care ...
Image source: The Motley Fool. Evolus Inc (NASDAQ: EOLS) Q2 2020 Earnings Call Aug 10, 2020 , 4:30 p.m. ET Operator Continue reading
Evolus, Inc. (EOLS) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Ashwin Agarwal - Vice President, Finance, Investor Relations and Treasury David Moatazedi - President and Chief Executive Officer Mike Jafar - Chief Marketing Officer Rui Avel...
The following slide deck was published by Evolus, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Evolus (NASDAQ: EOLS ) : Q2 GAAP EPS of -$0.63 beats by $0.16 . More news on: Evolus, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2020 financial results and provide a busine...
Gainers: Corvus Pharmaceuticals (NASDAQ: CRVS ) +108% . More news on: Corvus Pharmaceuticals, Inc., Annovis Bio, Inc., Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Evolus (NASDAQ: EOLS ) -37% on potential barrier to Jeuveau sales in U.S. More news on: Evolus, Inc., Remark Holdings, Inc., Unum Therapeutics Inc., Stocks on the move, , Read more ...
NEWPORT BEACH, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced that its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40 million in a five-year, unsecured, subordinated, 3% convertible note in the Company at a conversion price of $13...
News, Short Squeeze, Breakout and More Instantly...
Total Net Revenue of $66.9 Million for Q2 2024, Up 36% from Q2 2023 Raises Full-Year 2024 Net Revenue Guidance to $260 Million to $270 Million, Representing Year-Over-Year Growth of 34% at the Top End Improved Quarterly GAAP Operating Loss to $7.7 Million; Delivered First Ever Qua...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will host an Investor Day on Thursday, September 12, 2024 in New York City. Attendees can join in-person or participate via webcast. The even...
Launching into this growth market 1 as part of the company’s geographic expansion strategy Evolus Australia established to drive medical education, training, marketing and sales to medical aesthetics healthcare professionals Evolus, Inc. (NASDAQ: EOLS), a perf...